# interest areas
- [myDiabetesIQ](http://www.mywaydigitalhealth.co.uk/)

- use of Recurrent Neural Networks / Convolutional Neural Networks to extract information from time-series data in diabetes to allow regression / classification analysis. Applications include [prediction of mortality from HbA1c time series analysis](https://github.com/csainsbury/bagOfDrugs/tree/master/local_py), [prediction of inpatient outcomes from pre-admission data](https://github.com/csainsbury/machineLearning.hypoglycaemiaDuringAdmission) and [individualised virtual n=1 drug trials to allow optimum drug selection](https://github.com/csainsbury/nEqOneTrial)

- [use of unsupervised ML algorithms to identify incorrected entered data within large scale diabetes datasets](https://github.com/csainsbury/t1_t2_ANN)

- continuous risk stratification of inpatients with diabetes
- association of inpatient glucose metrics and long term outcomes
- mechanisms linking glucose and CV risk in diabetes
- [problem drug use and diabetes](https://github.com/csainsbury/problemDrugUse.diabetes)
- cystic fibrosis related diabetes
- multiscale variability in glucose metrics and association with outcome
- [efficacy of structured intervention on glycaemic endpoints](https://github.com/csainsbury/DICE)
- clustering within type 2 diabetes
- synthetic clinical data generation using gan
- prediction of steroid induced hyperglycaemia




# people
__Current__

- __[Dr Chris Sainsbury](https://www.birmingham.ac.uk/staff/profiles/applied-health/sainsbury-chris.aspx)__ Consultant Diabetes & Endocrinology. @csainsbury. x@y where x=christopher.sainsbury & y=ggc.scot.nhs.uk
- __Dr Greg Jones__ Consultant Diabetes & Endocrinology. Honorary Associate Professor, @gregcjones. x@y where x=greg.jones & y=nhs.scot
- __Dr Debbie Morrison__ GPSI Diabetes. Honorary Clinical Lecturer
- __Dr Conor Pádraig McKeag__ Clinical Research Fellow. x@y where x=conor.mckeag & y=ggc.scot.nhs.uk
- __Dr Hannah Barker__ Academic Foundation Trainee

Onboarding information [here](https://glucose.ai/onboarding)

__Previous__

- __Dr Sean Harbison__ Clinical Development Fellow

# output
__2022__
Greenwood, David, Thomas Taverner, Nicola J. Adderley, Malcolm James Price, Krishna Gokhale, Christopher Sainsbury, Suzy Gallier, et al. 2022. “Machine Learning of COVID-19 Clinical Data Identifies Population Structures with Therapeutic Potential.” iScience 25 (7): 104480.

__2022__
Wang, Zhaonan, Jonathan Hazlehurst, Anuradhaa Subramanian, Abd A. Tahrani, Wasim Hanif, Neil Thomas, Pushpa Singh, et al. 2022. “Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study.” Frontiers in Endocrinology 13 (July): 888924.

__2022__
Gokhale, Krishna, Samiul A. Mostafa, Jingya Wang, Abd A. Tahrani, Christopher Andrew Sainsbury, Konstantinos A. Toulis, G. Neil Thomas, et al. 2022. “The Clinical Profile and Associated Mortality in People with and without Diabetes with Coronavirus Disease 2019 on Admission to Acute Hospital Services.” Endocrinology, Diabetes & Metabolism 5 (1): e00309.

__2022__
Adderley, Nicola J., Thomas Taverner, Malcolm James Price, Christopher Sainsbury, David Greenwood, Joht Singh Chandan, Yemisi Takwoingi, et al. 2022. “Development and External Validation of Prognostic Models for COVID-19 to Support Risk Stratification in Secondary Care.” BMJ Open 12 (1): e049506.

__2021__
Haroon, Shamil, Anuradhaa Subramanian, Jennifer Cooper, Astha Anand, Krishna Gokhale, Nathan Byne, Samir Dhalla, et al. 2021. “Renin-Angiotensin System Inhibitors and Susceptibility to COVID-19 in Patients with Hypertension: A Propensity Score-Matched Cohort Study in Primary Care.” BMC Infectious Diseases 21 (1): 262.

__2021__
Subramanian, Anuradhaa, Astha Anand, Nicola J. Adderley, Kelvin Okoth, Konstantinos A. Toulis, Krishna Gokhale, Christopher Sainsbury, Michael W. O’Reilly, Wiebke Arlt, and Krishnarajah Nirantharakumar. 2021. “Increased COVID-19 Infections in Women with Polycystic Ovary Syndrome: A Population-Based Study.” European Journal of Endocrinology / European Federation of Endocrine Societies 184 (5): 637–45.

__2021__
Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes. J Wang, J Cooper, K Gokhale, D Acosta-Mena, S Dhalla, N Byne, J Singh Chandan, A Anand, K Okoth, A Subramanian, MN Bangash, T Jackson, D Zemedikun, T Taverner, W Hanif, S Ghosh, P Narendran, K Toulis, A Tahrani, R Surenthirakumaran, NJ Adderley, S Haroon, K Khunti, C Sainsbury, GN Thomas, K Nirantharakumar. The Journal of Clinical Endocrinology & Metabolism. 2021.
[__web__](https://doi.org/10.1210/clinem/dgab067)

__2021__
Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care. Nicola J Adderley, Thomas Taverner, Malcolm Price, Christopher Sainsbury, David Greenwood, Joht Singh Chandan, Yemisi Takwoingi, Rashan Haniffa, Isaac Hosier, Carly Welch, Dhruv Parekh, Suzy Gallier, Krishna M Gokhale, Alastair K Denniston, Elizabeth Sapey, Krishnarajah Nirantharakumar. Preprint. Medrxiv. 30 Jan 2021.
[__web__](https://doi.org/10.1101/2021.01.25.21249942)

__2021__
Social Deprivation and Incident Diabetes-Related Foot Disease in Patients With Type 2 Diabetes: A Population-Based Cohort Study. Jenny Riley, Christina Antza, Punith Kempegowda, Anuradhaa Subramanian, Joht Singh Chandan, Krishna Gokhale, Neil Thomas, Christopher Sainsbury, Abd A. Tahrani, Krishnarajah Nirantharakumar. Diabetes Care. 2021. https://doi.org/10.2337/dc20-1027
[__web__](https://doi.org/10.2337/dc20-1027)

__2020__
Non‐steroidal anti‐inflammatory drugs and susceptibility to COVID‐19. Joht Singh Chandan, Dawit Tefra Zemedikun, Rasiah Thayakaran, Nathan Byne, Samir Dhalla, Dionisio Acosta‐Mena, Krishna M Gokhale, Tom Thomas, Christopher Sainsbury, Anuradhaa Subramanian, Jennifer Cooper, Astha Anand, Kelvin O Okoth, Jingya Wang, Nicola J Adderley, Thomas Taverner, Alastair K Denniston, Janet Lord, G. Neil Thomas, Christopher D Buckley, Karim Raza, Neeraj Bhala, Krishnarajah Nirantharakumar, Shamil Haroon. Arthritis and Rheumatology. 2020. https://doi.org/10.1002/art.41593
[__web__](https://doi.org/10.1002/art.41593)

__2020__
Sodium‐glucose‐co‐transporter‐2 inhibitors and susceptibility to COVID‐19: a population‐based retrospective cohort study. C Sainsbury, J Wang, K Gokhale, D Acosta‐Mena, S Dhalla, N Byne, J Singh Chandan, A Anand, J Cooper, K Okoth, A Subramanian, M Bangash, T Taverner, W Hanif, S Ghosh, P Narendran, KK Cheng, Tom Marshall, G Gkoutos, K Toulis PhD, GN Thomas PhD, A Tahrani, N Adderley, S Haroon, K Nirantharakumar. Diabetes Obesity and Metabolism 2020.  https://doi.org/10.1111/dom.14203 
[__web__](https://doi.org/10.1111/dom.14203)

__2020__
Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care. S Haroon,A Subramanian,J Cooper, A Anand, K Gokhale, N Byne, S Dhalla, D Acosta-Mena, T Taverner, K Okoth, J Wang, J Singh Chandan, C Sainsbury, D Zemedikun, GN Thomas,D Parekh, T Marshall, E Sapey, NJ Adderley, K Nirantharakumar. Preprint. Medrxiv. 18 Sep 2020. 
[__web__](https://www.medrxiv.org/content/10.1101/2020.09.17.20196469v1)

__2020__
Remodelling diabetes services and emerging innovation. DJ Wake, FW Gibb, P Kar, B Kennon, DC Klonoff, G Rayman, MK Rutter, C Sainsbury, RK Semple. European Journal of Endocrinology 183 (2). [__web__](https://eje.bioscientifica.com/view/journals/eje/183/2/EJE-20-0377.xml)

__2020__
Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort StudyNJ Adderley, A Subramanian, K Toulis, K Gokhale, T Taverner, W Hanif, S Haroon, GN Thomas, C Sainsbury, AA Tahrani, K Nirantharakumar. Diabetes Care | https://doi.org/10.2337/dc19-2116 | [__web__](https://care.diabetesjournals.org/content/early/2020/04/17/dc19-2116.abstract)

__2019__
Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. R Thayakaran, NJ Adderley, C Sainsbury, B Torlinska, K Boelaert, D Šumilo, M Price, GN Thomas, KA Toulis, K Nirantharakumar. BMJ 2019; 366 | https://doi.org/10.1136/bmj.l4892 | [__web__](https://www.bmj.com/content/366/bmj.l4892)

__2018__
Admission Glucose Number (AGN): A point of admission score associated with inpatient glucose variability, hypoglycaemia and mortality. J McKechnie, R Maitland, CAR Sainsbury, GC Jones. Journal of Diabetes Science and Technology | https://doi.org/10.1177/1932296818800722 | [__web__](http://journals.sagepub.com/doi/full/10.1177/1932296818800722)

__2018__
Identifying modifiable risk factors to reduce inpatient hypoglycaemia. PD Murray, BA McKee, CAR Sainsbury, GC Jones. Clinical Pharmacist, August 2018, Vol 10, No 8, online | DOI: 10.1211/CP.2018.20205227 | [__web__](https://www.pharmaceutical-journal.com/research/research-article/identifying-modifiable-risk-factors-to-reduce-inpatient-hypoglycaemia/20205227.article?firstPass=false)

__2018__
Structured education using Dose Adjustment for Normal Eating (DAFNE) reduces long term HbA1c and HbA1c variability. GS Walker, JY Chen, H Hopkinson, CAR Sainsbury, GC Jones. 2018. Diabetic Medicine | [__web__](https://onlinelibrary.wiley.com/doi/full/10.1111/dme.13621)

__2018__
Visit-to-visit HbA1c variability and systolic blood pressure (SBP) variability are significantly and additively associated with mortality in people with type 1 diabetes: an observational study. Stuart S. Wightman, Christopher A.R. Sainsbury, Gregory C. Jones. Diabetes Obesity & Metabolism | [__web__](http://onlinelibrary.wiley.com/doi/10.1111/dom.13193/full)

__2017__
HbA1c variability is associated with increased mortality and earlier hospital admission in people with type 1 diabetes. Graham S Walker, Scott G Cunningham, Christopher A.R. Sainsbury, Gregory C. Jones. Diabetic Medicine | [__web__](http://onlinelibrary.wiley.com/doi/10.1111/dme.13455/full)

__2017__
A practical review of C-Peptide Testing in Diabetes. E Leighton, C Sainsbury, G Jones. Diabetes Ther | [__web__](https://link.springer.com/article/10.1007%2Fs13300-017-0265-4) | [__.pdf__](http://rdcu.be/rSgE)

__2017__
Hypoglycemia and Clinical Outcomes in Hospitalized Patients With Diabetes: Does Association With Adverse Outcomes Remain When Number of Glucose Tests Performed Is Accounted For?
GC Jones, JG Timmons, SG Cunningham, SJ Cleland, CAR Sainsbury
Journal of Diabetes Science and Technology | [__web__](http://journals.sagepub.com/doi/abs/10.1177/1932296816688012) | [__.pdf__](http://journals.sagepub.com/doi/pdf/10.1177/1932296816688012)

__2016__
A Practical Approach to Glucose Abnormalities in Cystic Fibrosis
GC Jones, CAR Sainsbury | [__web__](https://link.springer.com/article/10.1007/s13300-016-0205-8) | [__.pdf__](https://link.springer.com/content/pdf/10.1007%2Fs13300-016-0205-8.pdf)

__2016__
Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia
GC Jones, J Khan, CAR Sainsbury | [__web__](https://link.springer.com/article/10.1007/s00592-016-0940-3) | [__.pdf__](https://link.springer.com/content/pdf/10.1007%2Fs00592-016-0940-3.pdf)

__2016__
Stroke and diabetes: a dangerous liaison
SL Macpherson, C Sainsbury, J Dawson, GC Jones | [__web__](http://bjdvd.co.uk/index.php/bjd/article/view/172) | [__.pdf__](http://bjdvd.co.uk/index.php/bjd/article/download/172/314)

__2016__
Living with asthma and chronic obstructive airways disease: using technology to support self-management – an overview. D Morrison,FS Mair, L Yardley, S Kirby, M Thomas | [__web__](http://journals.sagepub.com/doi/pdf/10.1177/1479972316660977)

__2016__
Patterns and impact of hypoglycemia, hyperglycemia, and glucose variability on inpatients with insulin-treated cystic fibrosis-related diabetes
GC Jones, ZM Chong, J Gilmour, C Matheson, G MacGregor, C Sainsbury | [__web__](http://link.springer.com/article/10.1007/s13300-016-0194-7) | [__.pdf__](https://link.springer.com/content/pdf/10.1007%2Fs13300-016-0194-7.pdf)

__2016__
Metformin increases cortisol regeneration by 11βHSD1 in obese men with and without type 2 diabetes mellitus
Anderson AJ, Andrew R, Homer NZ, Jones GC, Smith K, Livingstone DE, Walker BR, Stimson RH | [__web__](http://press.endocrine.org/doi/abs/10.1210/jc.2016-2069)

__2016__
Inpatient glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes
JG Timmons, SG Cunningham, CAR Sainsbury, GC Jones
[Journal of Diabetes and its Complications](http://www.sciencedirect.com/science/article/pii/S1056872716302148)

__2016__
Evaluation of a combination of SGLT2 inhibitor and GLP-1 receptor agonist treatment in type 2 diabetes
Hayden J, Huang F, McConnell LMJ, Sainsbury CAR, Jones GC
[Diabetes & Primary Care 18 (3): 135-138](http://www.diabetesandprimarycare.co.uk/journal-content/view/evaluation-of-a-combination-of-sglt2-inhibitor-and-glp-1-receptor-agonist-treatment-in-type-2-diabetes)

__2016__
Managing multimorbidity in primary care in patients with chronic respiratory conditions. npj Primary Care Respiratory Medicine, 26, 16043. 
D Morrison,K Agur, S Mercer, A Eiras, JI González-Montalvo, K Gruffydd-Jones
[Primary Care Respiratory Medicine, 26, 16043](http://www.nature.com/articles/npjpcrm201643)

__2016__
Experience of and predictors of response to dapagliflozin in a real-life cohort of people with type 2 diabetes 
Huang F, Hayden J, McConnell LMJ, Sainsbury CAR, Jones GC
[Journal of Diabetes Nursing 20 (7): 238-243](http://www.thejournalofdiabetesnursing.co.uk/journal-content/view/experience-of-and-predictors-of-response-to-dapagliflozin-in-a-real-life-cohort-of-people-with-type-2-diabetes)

__2015__
Capillary blood glucose monitoring, inpatient hypoglycaemia and quality of care
GC Jones, CG Perry, A Monaghan, B Kennon, CAR Sainsbury
[British Journal of Diabetes 15 (1), 24-26](http://www.bjd-abcd.com/index.php/bjd/article/view/50) [__(pdf)__](http://www.bjd-abcd.com/index.php/bjd/article/download/50/117)

__2015__
Comment on ‘A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure’
GC Jones, CAR Sainsbury
[Diabetic Medicine 32 (2), 287-287](http://onlinelibrary.wiley.com/doi/10.1111/dme.12626/abstract)

__2015__
Longitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients. L McCallum, J Panniyammakal, CE Hastie, J Hewitt, R Patel, GC Jones, S Muir, M Walters, N Sattar, AF Dominiczak, S Padmanabhan
[Hypertension 66 (1), 37-43](http://hyper.ahajournals.org/content/66/1/37.short) [__(pdf)__](http://hyper.ahajournals.org/content/66/1/37.full.pdf?download=true)

__2014__
Trends in recorded capillary blood glucose and hypoglycaemia in hospitalised patients with diabetes
GC Jones, H Casey, CG Perry, B Kennon, CAR Sainsbury. [Diabetes research and clinical practice 104 (1), 79-83](http://www.sciencedirect.com/science/article/pii/S0168822714000515)

__2014__
Dipeptidyl peptidase 4 inhibitors in routine clinical practice: experiences from a Scottish teaching hospital
AL Brown, CR Sainsbury, C Fenelon, AB Mullen, GC Jones
[British Journal of Diabetes 14 (4), 134-137](http://bjd-abcd.org.uk/index.php/bjd/article/view/38) [__(pdf)__](http://bjd-abcd.org.uk/index.php/bjd/article/view/38/92)

__2014__
Numerical simulation of blood flow and pressure drop in the pulmonary arterial and venous circulation
MU Qureshi, GDA Vaughan, C Sainsbury, M Johnson, CS Peskin, MS Olufsen, NA Hill
[Biomechanics and modeling in mechanobiology 13 (5), 1137-1154 ](http://link.springer.com/article/10.1007/s10237-014-0563-y)

__2013__
Long-Term and Ultra Long–Term Blood Pressure Variability During Follow-Up and Mortality in 14 522 Patients With Hypertension. CE Hastie, P Jeemon, H Coleman, L McCallum, R Patel, J Dawson, W Sloan, P Meredith, GC Jones, S Muir, M Walters, AF Dominiczak, D Morrison, GT McInnes, S Padmanabhan
[Hypertension 62 (4), 698-705](http://hyper.ahajournals.org/content/62/4/698.short) [__(pdf)__](http://hyper.ahajournals.org/content/62/4/698.full.pdf?download=true)

__2012__
Rarefaction and blood pressure in systemic and pulmonary arteries
MS Olufsen, NA Hill, GDA Vaughan, C Sainsbury, M Johnson
[Journal of fluid mechanics 705, 280-305](http://journals.cambridge.org/article_S0022112012002200)

__2012__
Hematocrit Predicts Long-Term Mortality in a Nonlinear and Sex-Specific Manner in Hypertensive AdultsNovelty and Significance
L Paul, P Jeemon, J Hewitt, L McCallum, P Higgins, M Walters, J McClure, ...
[Hypertension 60 (3), 631-638](http://hyper.ahajournals.org/content/60/3/631.short)

__2012__
Boerhaave's syndrome and diabetic ketoacidosis
K Mitchell, G Jones
[Practical Diabetes 29 (7), 268-268](http://onlinelibrary.wiley.com/doi/10.1002/pdi.1704/full)

__2011__
AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study
JG Boyle, PJ Logan, GC Jones, M Small, N Sattar, JMC Connell, ...
[Diabetologia 54 (7), 1799-1809](http://link.springer.com/article/10.1007/s00125-011-2126-4) 

# presentations
__2019__
Predicting mortality in both diabetes and open source clinical datasets from free text entries using machine learning (natural language processing) | Diabetes Technology Society. November 2019. Washington DC | [__.pdf__](./glucose_ai_presentation_files/DTS_poster.pdf)

__2019__
personalising risk prediction in diabetes using machine learning bridging the gap between RCT and RCD | Royal College of Physicians and Surgeons (Glasgow) | May 2019. Glasgow | [__.pdf__](./glucose_ai_presentation_files/rcpsg_dmml.pdf)

__2019__
data landscape presentation. march 2019 | [__.pdf__](./glucose_ai_presentation_files/dataLandscape.pdf)

__2018__
Machine learning approaches to (i) predicting response to therapy in diabetes, (ii) data-driven diabetes subtype classification and (iii) synthetic data generation. Dundee. 210618 | [__.pdf__](./glucose_ai_presentation_files/dundeeJune18.pdf) | [__.ppt__](./glucose_ai_presentation_files/dundeeJune18.pptx)

__2018__
Machine-Learning (neural network) driven algorithmic classification of Type 1 or Type 2 diabetes at the time of presentation significantly outperforms experienced clinician classification. DUK. London | [__.pdf__](./glucose_ai_presentation_files/DUK_poster_2.pdf)

__2018__
Parallel time-series analysis of HbA1c and Systolic BP using a recurrent neural network (RNN) stratifies for 1-year mortality in Type 2 Diabetes independent of age and parameter variability. DUK. London | [__.pdf__](./glucose_ai_presentation_files/DUK_poster_1.pdf)

__2018__
Parallel time-series analysis of HbA1c, Systolic Blood Pressure and BMI using Recurrent Neural Networks stratifies for 1-year mortality in T2DM, independent of age and parameter variability. ATTD. Vienna | [__.pdf__](./glucose_ai_presentation_files/ATTD_poster_1.pdf)

__2018__
Time-series analysis of HbA1c using Recurrent Neural Networks stratifies for 1-year mortality in Type 1 and Type 2 Diabetes, independent of age and variability. ATTD. Vienna | [__.pdf__](./glucose_ai_presentation_files/ATTD_poster_1.pdf)

__2017__
MyDiabetesIQ. machine learning for decision support & outcome prediction in diabetes. Automated Clinical Epidemiology Studies workshop, University of Birmingham. 141217 | [__.pdf__](./glucose_ai_presentation_files/MyDiabetesIQ_birmingham_dec17.pdf)

__2017__
Diabetes and opiate replacement therapy (ORT). A retrospective cohort study of health care usage and clinical outcomes. H Druce, D Morrison, C Sainsbury, R Lowrie, C Ritchie, GC Jones. Oral Presentation. RCGP, London | [__.pdf__](./glucose_ai_presentation_files/171103_RCGP_MDA_DM_london_slides_presented.pdf)

__2017__
Glucose dynamics and mortality in RRT patients: an initial report. Matthew A Rutherford, Gregory C Jones, Alan G Jardine, Patrick B Mark, Peter C Thomson, Christopher AR Sainsbury. Oral Presentation, SRA, Dunblane 2017 | [__.pdf__](./glucose_ai_presentation_files/RRTglycaemiaSRA.pdf)

__2017__
Diabetes and opiate replacement therapy (ORT). A retrospective cohort study of healthcare usage and clinical outcomes. H Druce, R Lowrie, C Ritchie, D Morrison, CAR Sainsbury, GC Jones. Poster Presentation, EASD, Lisbon 2017 | [__.pdf__](./glucose_ai_presentation_files/easd17.pdf)

__2017__
Serum chloride predicts mortality risk in type 2 diabetes – analysis of 91,159 patients from the West of Scotland. Linsay McCallum, Christopher A Sainsbury, Gregory C Jones, Sandosh Padmanabhan. AHA, 2017 | [__.pdf__](./glucose_ai_presentation_files/AHA_Cl_diabetes_040917_SP.pdf)

__2017__
Serum chloride is a mortality risk predictor in type 2 diabetes mellitus – analysis of 91,159 patients in the West of Scotland. Linsay McCallum, Christopher A Sainsbury Gregory C Jones, Sandosh Padmanabhan. Oral Presentation, ESH, Milan 2017 | [__.pdf__](./glucose_ai_presentation_files/ESH_Cl_diabetes_050617.pdf)

__2017__
Non-stimulated c-peptide is independently associated with requirement at 1 year for insulin therapy in paitnets with diabetes. A retrospective cohort study of 872 patients. EL Leighton, K Smith, SG Cunningham, CAR Sainsbury, GC Jones. Poster Presentation, ECE, Lisbon 2017 | [__.pdf__](./glucose_ai_presentation_files/cpepposterforECE2017.pdf)

__2017__
Admission Glucose Number (AGN): a novel score associated with adverse outcomes in patients admitted with Type 2 Diabetes. CAR Sainsbury, SG Cunningham, R Srivastava, GC Jones. Poster Presentation. Diabetes UK, Manchester 2017 | [__.pdf__](./glucose_ai_presentation_files/duk_agn_17.pdf)

__2017__
Glucose variability and risk of hypoglycaemia amongst inpatients with type 2 diabetes and its relationship to drug class exposure. KM Fairhurst, SG Cunningham, CAR Sainsbury, GC Jones. Poster Presentation. Diabetes UK, Manchester 2017 | [__.pdf__](./glucose_ai_presentation_files/DiabUK17_Drug_class_poster.pdf)

__2017__
Does pre-admission HbA1c predict inpatient glucose characteristics and outcomes in patients with diabetes? M Talla, SG Cunningham, CAR Sainsbury, GC Jones. Poster Presentation. Diabetes UK. Manchester March 2017 | [__.pdf__](./glucose_ai_presentation_files/Diab UK HbA1c Inpatient Glucose Characteristics.pdf)

__2017__ 
Admission Glucose Number (AGN): A novel point-of-admission score associated with prolonged admission duration, and with glycaemic characteristics in patients with Type 1 Diabetes. R Maitland, R Srivastava, S Cunningham, G Jones, C Sainsbury. 2017. ATTD, Paris. Oral Presentation | [__.pdf__](./glucose_ai_presentation_files/ATTD2017_3.pdf)

__2016__
Does type of diabetes, and treatment prescribed prior to admission influence quality of treatment of inpatient hypoglycaemia?
CAR Sainsbury, J Khan, GC Jones. British Endocrine Society. Oral Presentation | [__.pdf__](./glucose_ai_presentation_files/BES.pdf)
